Tirzepatide
Also called Mounjaro, Zepbound
A once-a-week GLP-1 and GIP medicine for weight loss and type 2 diabetes (Mounjaro, Zepbound).
- Usual amount
- 2.5–15 mg commonly reported
- How it’s taken
- Injection under the skin
- Half-life
- about 5 days half of it gone after
- Good after mixing
- 28 days in the fridge
Track this in StackbaseFree. Your doses, streaks and supplies in one private place.
What it is
Tirzepatide acts on two gut hormone receptors, GLP-1 and GIP. It curbs appetite and improves blood sugar. In the SURMOUNT-1 trial, people on the highest dose lost about 21% of their body weight over 72 weeks.
How it’s used
- Injected under the skin once a week.
- Start at 2.5 mg and go up by 2.5 mg after at least 4 weeks on each dose.
Typical amounts
- Labeled doses: 2.5, 5, 7.5, 10, 12.5 and 15 mg a week.
- 2.5 mg is a starting dose to get used to it, not a treatment dose.
Good to know
- Prescription medicine. Nausea, diarrhea and constipation are common early on and after dose increases.
- It can make birth control pills less reliable for 4 weeks after starting and after each increase.
- Not for people with a personal or family history of medullary thyroid cancer or MEN 2.
Educational information, not medical advice. Check anything you take with a doctor or pharmacist.